drugset / Trial / NCT06237595

Vagus Nerve Stimulation in Fibromyalgia

NCT06237595

Unknown 90 enrolled Kasr El Aini Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Vagus nerve stimulation is thought to reduce sympathetic nerve outflow and so can improve sympathetic hyperactivity in fibromyalgia patients. We aimed in the current study, to evaluate the effect of the cervical transcutaneous vagus nerve stimulation in comparison to conventional medical treatment in Egyptian fibromyalgia patients.

Timeline

Start
2023-09-30
Primary completion
2024-10-30
Completion
2025-02-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Duloxetine Small molecule 30 mg Oral
Comparator Gabapentin Small molecule 300 mg Oral

Indications